Showing 2341-2350 of 23151 results for "".
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
https://reachmd.com/programs/cme/breaking-new-ground-acoramidis-reduces-af-events-in-attr-cm-patients-from-esc-heart-failure-2025/36590/Review data from ESC Heart Failure 2025 on acoramidis and its association with reduced atrial fibrillation and improved outcomes in ATTR-CM.Integration of Photobiomodulation Therapy into the Age-Related Macular Degeneration Treatment Landscape
https://reachmd.com/programs/cme/Integration-of-Photobiomodulation-Therapy-into-the-Age-Related-Macular-Degeneration-Treatment-Landscape/35951/Learn about multiwavelength PBM for the treatment of dry AMD, including the MOA, administration, effAdvancing Cardiology and Heart Surgery Through a History of Collaboration
https://reachmd.com/programs/medical-industry-feature/advancing-cardiology-and-heart-surgery-through-a-history-of-collaboration/29915/Hear Dr. Craig Smith discuss the evolution of cardiac care, including the life-saving advancements he’s seen during his four-decade career as a cardiac surgeon.Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by MR Enterography
https://reachmd.com/programs/Audioabstracts/reliability-of-measuring-ileo-colonic-disease-activity-in-crohns-disease-by-mr-enterography/10610/Join us for an in-depth review of the reliability of magnetic resonance enterography and the London Index in assessing luminal Crohn's disease.Triglyceride-Lowering Therapies: Addressing Gaps in the Guidelines
https://reachmd.com/programs/lipid-luminations/triglyceride-lowering-therapies-addressing-gaps-in-guidelines/8340/Dr. Dixon discusses current guidelines for treating hypertriglyceridemia, how gaps are addressed, and which lipid-lowering therapies are emerging.Bridging The Cardiology Gap: Care Priorities for Adults With Congenital Heart Disease
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/bridging-cardiology-gap-care-priorities-adults-congenital-heart-disease/8031/A sizable population of adults are living with congenital heart disease. Dr Yuli Kim discusses the special care strategies needed for these patients.Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
https://reachmd.com/programs/acc-action-center/early-aggressive-lipid-lowering-strategy-with-PCSK9-siRNA-performs-better-than-usual-care-in-us-patients-with-ascvd/24289/ACC.24 - A structured approach to treat hypercholesterolemia with an "inclisiran first" strategy in US patients with ASCVD performs much better than usual care, according to Michael Koren. He hopes that the results of VICTORION-INITIATE are a wake-up call to treat patients more aggressively with lipCardio-Oncology: Key Clinical Data from ACC.23
https://reachmd.com/programs/acc-action-center/cardio-oncology-key-clinical-data-from-acc23/15144/Get the latest clinical data in cardio-oncology from the American College of Cardiology's 72nd Scientific Session & Expo.SPECIAL REPORT: Expert Opinion on New MS Drug Approval
https://reachmd.com/programs/global-neurology-academy/special-report-expert-opinion-new-ms-drug-approval/9794/Expert insight into the recent approval of Cladribine for active relapsing multiple sclerosis.National Amyotrophic Lateral Sclerosis (ALS) Registry: Impact, Challenges, and Future Directions
https://reachmd.com/programs/grand-rounds-nation/national-amyotrophic-lateral-sclerosis-als-registry-impact-challenges-and-future-directions/9529/CDC experts discuss the challenges for research, drug development, patient care, and the past, present and future of the national registry.